Mycket händer på läkemedelsområdet, både nationellt och i olika internationella instanser.

Regeringsuppdraget redovisas

Läkemedelsverket och Naturvårdsverket har rapporterat sina regeringsuppdrag att analysera insatser för att minska miljöpåverkan av läkemedel vid produktion och användning. Detta hör ihop med arbetet inom WHO och EU om grön upphandling av läkemedel och medicinsktekniska produkter.


Ökad miljöhänsyn i EU:s läkemedelslagstiftning och internationellt  
Miljökrav vid produktion av läkemedel inom EU
Redovisning av regeringsuppdrag Miljökrav vid produktion av läkemedel inom EU PM 2014-10-09


Läkemedelsverket har analyserat handlingsvägar för att uppnå minskad miljöpåverkat av läkemedel 
Fördjupad analys av olika handlingsalternativ för att nå etappmålet om miljöhänsyn i läkemedelslagstiftningen inom EU och internationellt 2014-12-14

Nya rapporter

Två nya rapporter, med sammanställningar av vad vi vet idag, har publicerats lagom för mötet med SAICM:s arbetsgrupp i december (se nedan).

Pharmaceuticals in the environment - a global perspective Umwelt Bundesamt, 2014 inför 

Medicines in the environment: A growing threat to wildlife and drinking water. ChemTrust, 7.12.2014

Framgång i SAICM 

För andra gången togs förslaget om läkemedel upp i arbetsgruppen (OEWG 2) för SAICM, FN:s miljöorgan för kemikalier. Till ISDE (International Society of Doctors for the Environment) som förslagsställare fogades Uruguay och Peru. OEWG 2 beslöt att nominera EPPP (Environmental Persistent Pharmaceutical Pollutants) som en "emerging policy issue" till SAICM hösten 2015.

I processen har Tyskland varit mycket aktivt. Representanter för svenska myndigheter (KemI, Läkemedelsverket) och departement har följt förloppet och stött förslaget.

Läs mer hos Umwelt Bundesamt
2nd meeting of OEWG, Geneva, 15-17 December 2014
Uppdaterat underlag för beslut

Rapport i Earth Negotiations Bulletin 2014:15;217 (17.12.2014):

NEW PROPOSED EMERGING POLICY ISSUE FOR CONSIDERATION BY ICCM4: ENVIRONMENTALLY PERSISTENT PHARMACEUTICAL POLLUTANTS: The Secretariat presented its note on EPPPs (SAICM/OEWG.2/7) and the nomination as submitted by the proponents of the proposal (SAICM/OEWG.2/INF/15).

URUGUAY, PERU and ISDE urged support for putting the proposal on the ICCM4 agenda and for reaching agreement at ICCM4 on making EPPPs a new EPI.

GRULAC, NORWAY, the AFRICAN GROUP, SWITZERLAND, HEALTHCARE WITHOUT HARM, CHINA, REPUBLIC OF KOREA and LIBERIA supported the proposal, with the AFRICAN GROUP requesting a contact group to discuss it further.

While welcoming the proposal as a good basis for discussion, the EU suggested streamlining the focus of any EPPP programme. CANADA stressed the importance of involving national and international experts on both the ecological and health aspects in any SAICM activity on EPPPs. The US said it was prepared to work with the proponents to fine-tune the proposal to ensure it was within the scope of SAICM. UNEP noted some overlap with work on EDCs, and urged using the time until ICCM4 to clarify the scope.

WHO expressed appreciation for the invitation to lead work on any EPPP work, but not alone as some aspects of the proposal fall outside WHO’s mandate.

The EPI contact group was tasked with reviewing the EPPPs proposal.



Rapport i Chemical Watch, 17 December 2014:

ICCM4 to tackle problem pharmaceuticals and pesticides

Saicm preparatory meeting agrees proposal on road to 2020

Environmentally persistent pharmaceutical pollutants (EPPPs) and highly hazardous pesticides (HHPs) will be discussed at the fourth International Conference on Chemicals Management (ICCM4), which is scheduled for September, next year.

At a Strategic Approach to International Chemicals Management (Saicm) meeting in Geneva this week, the second open-ended working group (OEWG2) discussed both topics and decided they should be presented to the conference.

A revised proposal to make EPPPs an emerging policy issue under Saicm at ICCM4 was submitted by Peru, Uruguay and  the International Society of Doctors for the Environment (ISDE). It is seeking greater visibility and policy engagement on the issue, as well as better coordination, consistency and synergies between different initiatives around the world and the engagement of stakeholders from different sectors. The document lists expected outcomes as:

  • expert guidance for risk identification and assessment;
  • priority setting for research and for risk management and control actions of environmental effects; and
  • information exchange and networking, from which scientists and policy makers in developing countries and countries with economies in transition could especially benefit, resulting in greater understanding of EPPP issues and needs for priority actions.

During the plenary session, many countries with developing and transitioning economies supported the draft proposal. A concern raised by the US and Canada on whether it was within Saicm’s scope was addressed during a contact group meeting, which saw references to the manufacture of pharmaceuticals removed from it.


Dela på:
Template by JoomlaShine